Form 4: Alumis Inc. Chief Legal Officer Sara Klein Acquires Stock Options
SEC Form 4 Filing
Alumis Inc.'s Chief Legal Officer, Sara Klein, reports the acquisition of stock options in the company.
Summary
- On February 18, 2025, Sara Klein, the Chief Legal Officer of Alumis Inc., acquired stock options for 180,000 shares of Alumis Inc. common stock.
- The exercise price for these options is $5.06 per share.
- The options vest over time, with 25% vesting on February 18, 2026, and the remainder vesting in equal monthly installments over the subsequent 36 months, contingent upon continuous service to Alumis Inc.
- The options expire on February 17, 2035.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, suggesting stability and alignment of interests. It's a neutral to slightly positive indicator.
Positives
- The acquisition of stock options by a key officer aligns her interests with those of the shareholders, potentially incentivizing her to work towards the company's success.
Future Outlook
The vesting schedule of the options suggests a long-term commitment from the Chief Legal Officer to the company.
Industry Context
Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.
Comparison to Industry Standards
- Stock option grants are a typical component of compensation packages for executives in publicly traded companies, particularly in the biotech sector.
- Companies like Amgen, Gilead Sciences, and Biogen often use stock options as part of their executive compensation to incentivize performance and align interests with shareholders.
- The vesting schedule of these options, with a portion vesting after one year and the remainder over the following three years, is also a common practice in the industry.
Stakeholder Impact
- Shareholders may view the stock option grant positively as it aligns the executive's interests with the company's long-term success.
- Employees may see this as a sign of stability and commitment from the leadership team.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of transaction: Sara Klein acquired stock options. |
| 02/18/2026 | 25% of the stock options vest. |
| 02/17/2035 | Expiration date of the stock options. |
Keywords
stock options, Form 4, insider trading, Alumis Inc., Sara Klein, Chief Legal Officer, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.